Biogen completes $5.3B acquisition of Apellis Pharmaceuticals, funded by $2B in new debt.

{
  "signal_id": "4d4719ff-45fb-484a-bd0b-feb256a50995",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-05-19T10:14:18.649+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "detail": "Biogen has completed its acquisition of Apellis, triggering a massive post-merger integration effort. This creates immediate needs for system consolidation (IT, HR, Finance), process harmonization, and data migration, presenting a prime opportunity for vendors specializing in M&A integration and enterprise software.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "Aggregate amount paid for the acquisition of Apellis Pharmaceuticals",
      "dollar_millions": 5300
    },
    "summary": "Biogen completes $5.3B acquisition of Apellis Pharmaceuticals, funded by $2B in new debt.",
    "excerpts": "The aggregate amount to be paid by Purchaser in the Offer and the Merger is approximately $5.3 billion, excluding related fees and expenses...",
    "relevance": 1,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/875045/000119312526222908/d109852d8k.htm",
    "filing_date": "2026-05-14",
    "filing_year": 2026,
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Apellis Pharmaceuticals, Inc."
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/4d4719ff-45fb-484a-bd0b-feb256a50995 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'